Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. financial statements
Collegium Pharmaceutical, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 780.57M | 10-K |
| Net income | USD 62.87M | 10-K |
| Cash and equivalents | USD 231.25M | 10-Q |
| Total debt | USD 940.56M | EODHD |
Collegium Pharmaceutical, Inc. financials on 6ix · Collegium Pharmaceutical, Inc. on 6ix